Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0O5XF
|
||||
| Former ID |
DIB006876
|
||||
| Drug Name |
CeaVac
|
||||
| Synonyms |
Idiotypic vaccine (CEA), Titan; Monoclonal antibody (cancer), Titan
|
||||
| Drug Type |
Vaccine
|
||||
| Indication | Colorectal cancer [ICD9: 153, 154; ICD10:C18-C21] | Phase 2 | [521450] | ||
| Company |
Titan Pharmaceuticals
|
||||
| CAS Number |
CAS 339150-51-5
|
||||
| Target and Pathway | |||||
| Target(s) | Carcinoembryonic antigen-related cell adhesion molecule 5 | Target Info | [525630] | ||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.